The insulin dosage market in Slovenia has experienced fluctuations over the past decade, reaching a market size of 36.304 million USD in 2023. From 2013 to 2023, the market saw its peak in 2014 before entering a period of gradual decline, hitting a low in 2020. Since then, it has seen modest recovery with slight year-on-year growth of 0.66% in 2023. Over the last five years, the compound annual growth rate (CAGR) was -1.13%, indicating a relatively stable yet contracting market.
Future trends to watch:
- The integration of digital health technologies and telemedicine in diabetes management could drive market growth.
- Potential price adjustments due to policy changes or increased competition could impact the market size.
- Demographic shifts and an aging population may influence demand for insulin products.
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 21 | 21 Switzerland | 53,245,000 | 2023 | -2.3% | -1.88% | View data |
| 22 | 22 Morocco | 42,235,000 | 2023 | +1.18% | +1.18% | View data |
| 23 | 23 Slovenia | 36,304,000 | 2023 | +0.66% | -1.13% | |
| 24 | 24 Lithuania | 34,051,000 | 2023 | -2.22% | -2.71% | View data |
